Effect of oral contraceptive use on lipid profile in Korean women aged 35-55 years

Contraception

Volumn 86, Issue 5, 2012, Pages 500-505

  Kim, Kisok ^a   Park, Hyejin ^b  

^a Keimyung University   (South Korea)

^b Kyungpook National University   (South Korea)

Author keywords

Cholesterol; Dyslipidemia; KNHANES; Oral contraceptive; Triglyceride

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL CONTRACEPTIVE AGENT; TRIACYLGLYCEROL;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIETARY INTAKE; FEMALE; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CONTRACEPTIVES, ORAL; CROSS-SECTIONAL STUDIES; DIET; FEMALE; HUMANS; HYPERLIPIDEMIAS; LIPIDS; MIDDLE AGED; QUESTIONNAIRES; REPUBLIC OF KOREA; TRIGLYCERIDES;

EID: 84867074984     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2012.04.004     Document Type: Article

References (31)

1. G. Benagiano, C. Bastianelli, and M. Farris Contraception today Ann N Y Acad Sci 1092 2006 1 32
2. P.S. David, E.A. Boatwright, and B.S. Tozer Hormonal contraception update Mayo Clin Proc 81 2006 949 954
3. I.F. Godsland, D. Crook, and V. Wynn Clinical and metabolic considerations of long-term oral contraceptive use Am J Obstet Gynecol 166 6 Pt 2 1992 1955 1963
4. B.A. Frempong, M. Ricks, S. Sen, and A.E. Sumner Effect of low-dose oral contraceptives on metabolic risk factors in African-American women J Clin Endocrinol Metab 93 2008 2097 2103
5. A. Foryst-Ludwig, and U. Kintscher Metabolic impact of estrogen signalling through ERalpha and ERbeta J Steroid Biochem Mol Biol 122 2010 74 81
6. P.S. Cooke, and A. Naaz Role of estrogens in adipocyte development and function Exp Biol Med 229 2004 1127 1135
7. P.S. Cooke, P.A. Heine, J.A. Taylor, and D.B. Lubahn The role of estrogen and estrogen receptor-alpha in male adipose tissue Mol Cell Endocrinol 178 2001 147 154
8. G. Bryzgalova, L. Lundholm, and N. Portwood Mechanisms of antidiabetogenic and body weight-lowering effects of estrogen in high-fat diet-fed mice Am J Physiol Endocrinol Metab 295 2008 E904 E912
9. F.A. Barreiros, C.A. Guazzelli, R. Barbosa, M.R. Torloni, M. Barbieri, and F.F. Araujo Extended regimens of the combined contraceptive vaginal ring containing etonogestrel and ethinyl estradiol: effects on lipid metabolism Contraception 84 2011 155 159
10. I.F. Godsland, D. Crook, and R. Simpson The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism N Engl J Med 323 1990 1375 1381
11. M. Notelovitz, E.B. Feldman, M. Gillespy, and J. Gudat Lipid and lipoprotein changes in women taking low-dose, triphasic oral contraceptives: a controlled, comparative, 12-month clinical trial Am J Obstet Gynecol 160 1989 1269 1280
12. H. Scharnagl, G. Petersen, M. Nauck, A.T. Teichmann, H. Wieland, and W. März Double-blind, randomized study comparing the effects of two monophasic oral contraceptives containing ethinylestradiol (20 microg or 30 microg) and levonorgestrel (100 microg or 150 microg) on lipoprotein metabolism Contraception 69 2004 105 113
13. S.O. Skouby, J. Endrikat, and B. Düsterberg A 1-year randomized study to evaluate the effects of a dose reduction in oral contraceptives on lipids and carbohydrate metabolism: 20 microg ethinyl estradiol combined with 100 microg levonorgestrel Contraception 71 2005 111 117
14. V. Wynn, P.W. Adams, and I. Godsland Comparison of effects of different combined oral-contraceptive formulations on carbohydrate and lipid metabolism Lancet 1 1979 1045 1049
15. H.B. Brewer Jr. Clinical review: the evolving role of HDL in the treatment of high-risk patients with cardiovascular disease J Clin Endocrinol Metab 96 2011 1246 1257
16. M.H. Davidson, and P.P. Toth High-density lipoprotein metabolism: potential therapeutic targets Am J Cardiol 100 11 A 2007 S32 S40
17. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
18. V. Hanak, J. Munoz, J. Teague, A. Stanley Jr., and V. Bittner Accuracy of the triglyceride to high-density lipoprotein cholesterol ratio for prediction of the low-density lipoprotein phenotype B Am J Cardiol 94 2004 219 222
19. J.A. Welsh, A. Sharma, J.L. Abramson, V. Vaccarino, C. Gillespie, and M.B. Vos Caloric sweetener consumption and dyslipidemia among US adults JAMA 303 2010 1490 1497
20. L. Speroff, and A. DeCherney Evaluation of a new generation of oral contraceptives. The Advisory Board for the New Progestins Obstet Gynecol 81 1993 1034 1047
21. B. Kaplan Desogestrel, norgestimate, and gestodene: the newer progestins Ann Pharmacother 29 1995 736 742
22. A. Lipson, D.B. Stoy, and J.C. LaRosa Progestins and oral contraceptive-induced lipoprotein changes: a prospective study Contraception 34 1986 121 134
23. A. Cagnacci, S. Ferrari, A. Tirelli, R. Zanin, and A. Volpe Insulin sensitivity and lipid metabolism with oral contraceptives containing chlormadinone acetate or desogestrel: a randomized trial Contraception 79 2009 111 116
24. C. Klipping, and J. Marr Effects of two combined oral contraceptives containing ethinyl estradiol 20 microg combined with either drospirenone or desogestrel on lipids, hemostatic parameters and carbohydrate metabolism Contraception 71 2005 409 416
25. A.B. Berenson, M. Rahman, and G. Wilkinson Effect of injectable and oral contraceptives on serum lipids Obstet Gynecol 114 2009 786 794
26. U.H. Winkler, and R. Sudik The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters Contraception 79 2009 15 23
27. P. Wahl, C. Walden, and R. Knopp Effect of estrogen/progestin potency on lipid/lipoprotein cholesterol N Engl J Med 308 1983 862 867
28. S. Graff-Iversen, and S. Tonstad Use of progestogen-only contraceptives/medications and lipid parameters in women age 40 to 42 years: results of a population-based cross-sectional Norwegian Survey Contraception 66 2002 7 13
29. V.J. Carey, L. Bishop, N. Laranjo, B.J. Harshfield, C. Kwiat, and F. Sacks Contribution of high plasma triglycerides and low high-density lipoprotein cholesterol to residual risk of coronary heart disease after establishment of low-density lipoprotein cholesterol control Am J Cardiol 106 2010 757 763
30. D.J. Gordon, J.L. Probstfield, and R.J. Garrison High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies Circulation 79 1989 8 15
31. N.E. Day, M.Y. Wong, and S. Bingham Correlated measurement error - implications for nutritional epidemiology Int J Epidemiol 33 2004 1373 1381